Clinics and pathology
Prognosis
In one study, patients with localized t(2;13) and t(1;13)-positive ARMS had comparable outcomes whereas a recent study with small numbers suggested that localized t(1;13) tumors had a better outcome than those with localized t(2;13) tumors. Among patients presenting with metastatic disease, those with t(1;13)-positive tumors had a significantly better outcome than those with t(2;13)-positive tumors. Note: these studies are based on molecular detection of the translocations.
Cytogenetics

Cytogenetics Morphological
Though a balanced 1;13 is sometimes visible in cases with the associated molecular fusion event, in many cases the balanced translocation is not visible. Instead the molecular fusion is found associated with a subsequent amplification event, usually double minute chromosomes.
Diagram of t(1;13)(p36;q14) chromosomal translocation.
Cytogenetics Molecular
The product of the 1;13 translocation is amplified in ~90% of t(1;13)-positive cases.
Additional anomalies
Amplification events involving 2p24 and 13q31 (as determined by DNA-based array studies).
Genes involved and proteins
PAX7
Location 1p36 Protein Transcription factor -paired box (PAX) family.
FOXO1 (FKHR)
Location 13q14 Protein Transcription factor -forkhead box (FOX) family.
Result of the chromosomal anomaly
Hybrid Gene
Description The 1;13 translocation breaks within intron 7 of the PAX7 gene and intron 1 of the FOXO1 gene on chromosome 13 to generate a PAX7-FOXO1 fusion gene as well as a reciprocal FOXO1-PAX7 fusion gene. In ~55% of PAX7-FOXO1-positive ARMS tumors, this FOXO1-PAX3 gene is not detectable. In cases with fusion gene amplification, the PAX7-FOXO1 fusion gene is amplified whereas the reciprocal FOXO1-PAX7 fusion gene is not. Transcript The PAX7-FOXO1 fusion transcript consists of the first 7 exons of PAX3 fused to FOXO1 exons 2 and 3. There is evidence that the PAX7-FOXO1 fusion transcript is upregulated relative to the wild-type PAX7 transcript, presumably due to increased copy number of the fusion gene by amplification. 
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